How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma

References

• Guo XX, An S, Yang Y, Liu Y, Hao Q, Xu TR. Rap-interacting proteins are key players in the rap symphony orchestra. Cell. Physiol. Biochem. 39(1), 137–156 (2016).
   PubMedGoogle Scholar
• Ohba Y, Ikuta K, Ogura A et al. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J. 20(13), 3333–3341 (2001).
   PubMed Web of Science ®Google Scholar
• Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4(8), 741–748 (2003).
   PubMed Web of Science ®Google Scholar
• Kooistra MR, Dubé N, Bos JL. Rap1: a key regulator in cell-cell junction formation. J. Cell Sci. 120(Pt 1), 17–22 (2007).
   PubMed Web of Science ®Google Scholar
• Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL. Cell–cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim. Biophys. Acta. 1788(4), 790–796 (2009).
   PubMed Web of Science ®Google Scholar
• Hogan C, Serpente N, Cogram P et al. Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol. Cell. Biol. 24(15), 6690–6700 (2004).
   PubMed Web of Science ®Google Scholar
• Priego N, Arechederra M, Sequera C et al. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms. Oncotarget 7(29), 45060–45078 (2016).
   PubMedGoogle Scholar
• Shimonaka M, Katagiri K, Nakayama T et al. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J. Cell Biol. 161(2), 417–427 (2003).
   PubMed Web of Science ®Google Scholar
• Schwamborn JC, Püschel AW. The sequential activity of the GTPases Rap1B and Cdc42 determines neuronal polarity. Nat. Neurosci. 7(9), 923–929 (2004).
   PubMed Web of Science ®Google Scholar
• Branham MT, Bustos MA, De Blas GA, Rehmann H, Zarelli VE, Treviño CL. Epac activates the small G proteins Rap1 and Rab3A to achieve exocytosis. J. Biol. Chem. 284(37), 24825–24839 (2009).
   PubMed Web of Science ®Google Scholar
• Maia V, Sanz M, Gutierrez-Berzal J et al. C3G silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival. Cell Signal. 21(7), 1229–1235 (2009).
   PubMed Web of Science ®Google Scholar
• Altschuler DL, Ribeiro-Neto F. Mitogenic and oncogenic properties of the small G protein Rap1b. Proc. Natl Acad. Sci. USA 95(13), 7475–7479 (1998).
   PubMed Web of Science ®Google Scholar
• Chen CH, Chuang HC, Huang CC et al. Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation. Am. J. Pathol. 182(2), 516–528 (2013).
   PubMed Web of Science ®Google Scholar
• Minato N. Rap G protein signal in normal and disordered lymphohematopoiesis. Exp. Cell Res. 319(15), 2323–2328 (2013).
   PubMed Web of Science ®Google Scholar
• Jeyaraj SC, Unger NT, Chotani MA. Rap1 GTPases: an emerging role in the cardiovasculature. Life Sci. 88(15–16), 645–652 (2011).
   PubMed Web of Science ®Google Scholar
• Radha V, Mitra A, Dayma K, Sasikumar K. Signalling to actin: role of C3G, a multitasking guanine-nucleotide-exchange factor. Biosci. Rep. 31(4), 231–244 (2011).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Berzal J, Casterllano E, Martín-Encabo S et al. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl. Exp. Cell Res. 312(6), 938–948 (2006).
   PubMed Web of Science ®Google Scholar
• Shivakrupa R, Radha V, Sudhakar Ch, Swarup G. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain. J. Biol. Chem. 278(52), 52188–52194 (2003).
   PubMed Web of Science ®Google Scholar
• Ichiba T, Hashimoto Y, Nakaya M, Kuraishi Y, Tanaka S, Kurata T. Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. J. Biol. Chem. 274(20), 14376–14381 (1999).
   PubMed Web of Science ®Google Scholar
• Tanaka S, Morishita T, Hashimoto Y et al. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl Acad. Sci. USA 91(8), 3443–3447 (1994).
   PubMed Web of Science ®Google Scholar
• Guerrero C, Fernandez-Medarde A, Rojas JM, Font de Mora J, Esteban LM, Santos E. Transformation suppressor activity of C3G is independent of its CDC25-homology domain. Oncogene 16(5), 613–624 (1998).
   PubMed Web of Science ®Google Scholar
• de Jong R, van Wijk A, Heisterkamp N, Groffen J. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells. Oncogene 17(21), 2805–2810 (1998).
   PubMed Web of Science ®Google Scholar
• Arai A, Nosaka Y, Kanda E, Yamamoto K, Miyasaka N, Miura O. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion. J. Biol. Chem. 276(13), 10453–10462 (2001).
   PubMed Web of Science ®Google Scholar
• Voss AK, Gruss P, Thomas T. The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation. Development 130(2), 355–367 (2003).
   PubMed Web of Science ®Google Scholar
• Uemura N, Griffin JD. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J. Biol. Chem. 274(53), 37525–37532 (1999).
   PubMed Web of Science ®Google Scholar
• Chiang SH, Baumann CA, Kanzaki M et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410(6831), 944–948 (2001).
   PubMed Web of Science ®Google Scholar
• Sasi Kumar K, Ramadhas A, Nayak SC, Kaniyappan S, Dayma K1, Radha V. C3G (RapGEF1) a regulator of actin dynamics promotes survival and myogenic differentiation of mouse mesenchymal cells. Biochim. Biophys. Acta. 1853(10 Pt A), 2629–2639 (2015).
   PubMed Web of Science ®Google Scholar
• Shivakrupa R, Radha V, Sudhakar Ch, Swarup G. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain. J. Biol. Chem. 278(52), 52188–52194 (2003).
   PubMed Web of Science ®Google Scholar
• Radha V, Rajanna A, Gupta RK, Dayma K, Raman T. The guanine nucleotide exchange factor, C3G regulates differentiation and survival of human neuroblastoma cells. J. Neurochem. 107(5), 1424–1435 (2008).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Uzquiza A, Arechederra M, Molina I et al. C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms: involvement in cell death. Cell Signal. 22(3), 533–542 (2010).
   PubMed Web of Science ®Google Scholar
• Maia V, Sanz M, Gutierrez-Berzal J et al. C3G silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival. Cell Signal. 21(7), 1229–1235 (2009).
   PubMed Web of Science ®Google Scholar
• Voss AK, Krebs DL, Thomas T. C3G regulates the size of the cerebral cortex neural precursor population. EMBO J. 25(15), 3652–3663 (2006).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Herrero S, Maia V, Gutiérrez-Berzal J et al. C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity. Biochim. Biophys. Acta. 1823(8), 1366–1377 (2012).
   PubMed Web of Science ®Google Scholar
• Martín-Encabo S, Santos E, Guerrero C. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton. Exp. Cell Res. 313(18), 3881–3891 (2007).
   PubMed Web of Science ®Google Scholar
• Guerrero C, Martín-Encabo S, Fernández-Medarde A, Santos E. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth. Oncogene 23(28), 4885–4893 (2004).
   PubMed Web of Science ®Google Scholar
• Guvakova MA, Lee WS, Furstenau DK et al. The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I. Biochem. J. 463(2), 257–270 (2014).
   PubMedGoogle Scholar
• Okino K, Nagai H, Nakayama H et al. Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma. Int. J. Gynecol. Cancer 16(2), 763–771 (2006).
   PubMed Web of Science ®Google Scholar
• Hirata T, Nagai H, Koizumi K et al. Amplification, up-regulation and over-expression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers. J. Hum. Genet. 49(6), 290–295 (2004).
   PubMed Web of Science ®Google Scholar
• De Falco V, Castellone MD, De Vita G et al. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res. 67(1), 381–390 (2007).
   PubMed Web of Science ®Google Scholar
• Martín-Granado V, Ortiz-Rivero S, Carmona R et al. C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis. Oncotarget 8(67), 110994–111011 (2017).
   PubMedGoogle Scholar
• Rangarajan S, Enserink JM, Kuiperij HB et al. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J. Cell Biol. 160(4), 487–493 (2003).
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Sakurai A, Sano H et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25(1), 136–146 (2005).
   PubMed Web of Science ®Google Scholar
• Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105(5), 1950–1955 (2004).
   PubMed Web of Science ®Google Scholar
• Kooistra MR, Corada M, Dejana E, Bos JL. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett. 579(22), 4966–4972 (2005).
   PubMed Web of Science ®Google Scholar
• Muñoz-Llancao P, Henríquez DR, Wilson C et al. Exchange protein directly activated by cAMP (EPAC) regulates neuronal polarization through Rap1B. J. Neurosci. 35(32), 11315–11329 (2015).
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li X, Ding J. Characteristics of liver cancer stem cells and clinical correlations. Cancer Lett. 379(2), 230–238 (2015).
   PubMed Web of Science ®Google Scholar
• Lee JS, Heo J, Libbrecht L et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med. 12(4), 410–416 (2006).
   PubMed Web of Science ®Google Scholar
• Holczbauer A, Factor VM, Andersen JB et al. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology 145(1), 221–231 (2013).
   PubMed Web of Science ®Google Scholar
• Niu ZS, Niu XJ, Wang WH. Genetic alterations in hepatocellular carcinoma: An update. World J. Gastroenterol. 22(41), 9069–9095 (2016).
   PubMed Web of Science ®Google Scholar
• Tejeda-Maldonado J, García-Juárez I, Aguirre-Valadez et al. Diagnosis and treatment of hepatocellular carcinoma: an update. World J. Hepatol. 7(3), 362–376 (2015).
   PubMed Web of Science ®Google Scholar
• De Minicis S, Kisseleva T, Francis H et al. Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma. Dig. Liver Dis. 45(6), 450–459 (2013).
   PubMedGoogle Scholar
• Umeda S, Kanda M, Kodera Y. Emerging evidence of molecular biomarkers in hepatocellular carcinoma. Histol. Histopathol. 33(4), 343–355 (2017).
   PubMed Web of Science ®Google Scholar
• Ueno H, Shibasaki T, Iwanaga T et al. Characterization of the gene EPAC2: structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform. Genomics 78(1–2), 91–98 (2001).
   PubMed Web of Science ®Google Scholar
• Cheerathodi M, Vincent JJ, Ballif BA. Quantitative comparison of CrkL-SH3 binding proteins from embryonic murine brain and liver: Implications for developmental signaling and the quantification of protein species variants in bottom-up proteomics. J. Proteomics 125, 104–111 (2015).
   PubMed Web of Science ®Google Scholar
• Mahony R, Ahmed S, Diskin C, Stevenson NJ. SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell. Mol. Life Sci. 73(17), 3323–3336 (2016).
   PubMed Web of Science ®Google Scholar
• Gaudy AM, Clementi AH, Campbell JS, Smrcka AV, Mooney RA. Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes. J. Biol. Chem. 285(53), 41356–41365 (2010).
   PubMed Web of Science ®Google Scholar
• Cullen KA, McCool J, Anwer MS, Webster CR. Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 287(2), G334–G343 (2004).
   PubMed Web of Science ®Google Scholar
• Gates A, Hohenester S, Anwer MS, Webster CR. cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 beta/alpha in rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 296(4), G764–G774 (2009).
   PubMed Web of Science ®Google Scholar
• Johnston A, Ponzetti K, Anwer MS, Webster CR. cAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH2-terminal kinase. Am. J. Physiol. Gastrointest. Liver Physiol. 301(2), G385–G400 (2011).
   PubMed Web of Science ®Google Scholar
• Lin YL, Mettling C, Chou CK. Rap1-suppressed tumorigenesis is concomitant with the interference in ras effector signaling. FEBS Lett. 467(2–3), 184–188 (2000).
   PubMed Web of Science ®Google Scholar
• Su H, Yang JR, Xu T et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69(3), 1135–1142 (2009).
   PubMed Web of Science ®Google Scholar
• Sheng Y, Ding S, Chen K et al. Functional analysis of miR-101–3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Biochem. Cell Biol. 92(2), 152–162 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang L, Duan H, Yang Y. Knockdown of Rap2B inhibits the proliferation and invasion in hepatocellular carcinoma cells. Oncol. Res. 25(1), 19–27 (2017).
   PubMed Web of Science ®Google Scholar
• Cruise JL, Rafferty MP, Riehle MM. Cell-cycle regulated expression of Rap1 in regenerating liver. Biochem. Biophys. Res. Commun. 230(3), 578–581 (1997).
   PubMed Web of Science ®Google Scholar
• Chen XG, Xu CS, Liu YM. Involvement of ERK1/2 signaling in proliferation of eight liver cell types during hepatic regeneration in rats. Genet. Mol. Res. 12(1), 665–677 (2013).
   PubMed Web of Science ®Google Scholar
• Li JW, Wang GP, Fan JY, Chang CF, Xu CS. Eight paths of ERK1/2 signalling pathway regulating hepatocyte proliferation in rat liver regeneration. J. Genet. 90(3), 435–442 (2011).
   PubMed Web of Science ®Google Scholar
• Windmeier C, Gressner AM. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen. Pharmacol. 29(2), 181–196 (1997).
   PubMedGoogle Scholar
• Yokoyama U, Patel HH, Lai NC, Aroonsakool N, Roth DM, Insel PA. The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc. Natl Acad. Sci. USA 105(17), 6386–6391 (2008).
   PubMed Web of Science ®Google Scholar
• Insel PA, Murray F, Yokoyama U et al. cAMP and Epac in the regulation of tissue fibrosis. Br. J. Pharmacol. 166(2), 447–456 (2012).
   PubMed Web of Science ®Google Scholar
• Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol. Aspects Med. 29(1–2), 17–21 (2008).
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 6, 425–456 (2011).
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang F, Wu X, Lv X, Li J. EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1. Can. J. Physiol. Pharmacol. 94(5), 498–507 (2016).
   PubMed Web of Science ®Google Scholar
• BioGPS Portal. GeneAtlas U133A, gcrma. Tissue-specific pattern of RapGEF1 expression (2017). http://biogps.org/#goto=genereport&id=2889.
   Google Scholar
• GTExportal (GTEx Analysis Release V6P). Gene expression of RapGEF1 gene (2017). https://gtexportal.org/home/gene/RAPGEF1.
   Google Scholar
• GENT (Gene Expression across Normal and Tumoral Tissue) platform. RapGEF1 mRNA expression in normal and tumoral liver samples (2017). http://medicalgenome.kribb.re.kr/GENT/search/view_result.php.
   Google Scholar
• Firebrowse platform. Differential plot of RapGEF1 mRNA expression across different normal and tumoral samples (2017). http://medicalgenome.kribb.re.kr/GENT/search/view_result.php.
   Google Scholar
• Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
   PubMed Web of Science ®Google Scholar
• Gene Investigator Software. Open access tool to explore mRNA expression of different genes and samples, across different public datasets (2017). https://genevestigator.com/gv/.
   Google Scholar
• cBioportal for cancer genomics portal. Query for RapGEF1 gene in hepatocarcinoma in different datasets (2017). http://www.cbioportal.org/index.do?session_id=5a359f8d498eb8b3d5623002.
   Google Scholar
• OASIS Analitics platform. Summary of RapGEF1 alterations from different cancer projects (2017). http://www.oasis-genomics.org/martreport/?report=report&mart=gene_report&ensembl_gene_id=ENSG00000107263&datasets=hsapiens_gene_ensembl_oasis1hkugc.
   Google Scholar
• cBioportal for cancer genomics portal. Query for RapGEF1 gene in TCGA Hepatocarcinoma dataset, survival (2017). http://www.cbioportal.org/index.do?session_id=59c265e3498e5df2e295878c&show_samples=false&.
   Google Scholar
• Welsch ME, Kaplan A, Chambers JM et al. Multivalent small-molecule pan-RAS inhibitors. Cell 168(5), 878.e29–889.e29 (2017).
   Web of Science ®Google Scholar
• Hong L, Guo Y, BasuRay S et al. A pan-GTPase inhibitor as a molecular probe. PLoS One 10(8), e0134317 (2015).
   PubMed Web of Science ®Google Scholar
• Evelyn CR, Biesiada J, Duan X et al. Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzyme.. J. Biol. Chem. 290(20), 12879–12898 (2015).
   PubMed Web of Science ®Google Scholar
• Parnell E, Palmer TM, Yarwood SJ. The future of EPAC-targeted therapies: agonism versus antagonism. Trends Pharmacol. Sci. 36(4), 203–14 (2015).
   PubMed Web of Science ®Google Scholar
• Tsalkova T, Mei FC, Li S et al. Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc. Natl Acad. Sci. USA 109(45), 18613–18618 (2012).
   PubMed Web of Science ®Google Scholar
• Almahariq M, Tsalkova T, Mei FC et al. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol. Pharmacol. 83(1), 122–128 (2013).
   PubMed Web of Science ®Google Scholar
• Rehmann H. Epac-inhibitors: facts and artefacts. Sci. Rep. 3, 3032 (2013).
   PubMed Web of Science ®Google Scholar
• Zhu Y, Chen H, Boulton S, Mei F, Ye N. Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 “therapeutic window”. Sci. Rep. 5, 9344 (2015).
   PubMed Web of Science ®Google Scholar